IMMUNOTEC INC. ("IMM")
BULLETIN TYPE: Delist
BULLETIN DATE: May 19, 2017
TSX Venture Tier 1 Company
Further to the news releases of Immunotec Inc. (the "Company") dated March 22, April 19, May 11, 12 and 18, 2017, the common shares of the Company will be delisted from TSX Venture Exchange effective at the close of business on Friday, May 19, 2017.
The delisting of the Company's common shares results from the completion of an arm's length arrangement agreement with 1111267 B.C. Ltd., a subsidiary of Immuno Holding S.A. de C.V. ("Immuno Holding"), pursuant to which Immuno Holding has acquired all of the issued and outstanding common shares of the Company for a cash consideration of $0.485 per share.
The arrangement was approved by shareholders at a special shareholders' meeting held on May 11, 2017.
For more information, please consult the Company's Proxy Circular dated April 13, 2017.
IMMUNOTEC INC. ("IMM")
TYPE DE BULLETIN : Radiation de la cote
DATE DU BULLETIN : Le 19 mai 2017
Societe du groupe 1 de TSX Croissance
Suite aux communiques de presse de Immunotec inc. (la " societe ") emis les 22 mars, 19 avril, 11, 12 et 18 mai 2017, les actions ordinaires de la societe seront retirees de la cote de Bourse de croissance TSX a la fermeture des affaires le vendredi 19 mai 2017.
La radiation de la cote des actions ordinaires de la societe resulte de la realisation d'une convention d'arrangement avec 1111267 B.C. Ltd., une filiale de Immuno Holding S.A. de C.V. ("Immuno Holding"), en vertu de laquelle Immuno Holding a acquis toutes les actions ordinaires emises et en circulation de la societe pour une consideration de 0,485 $ en especes par action.
L'arrangement a ete approuve par les actionnaires lors d'une assemblee extraordinaire tenue le 11 mai 2017.
Pour plus de renseignements, veuillez consulter la circulaire de procuration par la direction datee du 13 avril 2017.
_______________________________________
|
|
